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Abstract
The pathogenic yeast Candida dubliniensis is increasingly reported as a cause of systemic fungal infections. We compared the virulence
of 9 clinical bloodstream isolates of C. dubliniensis with 3 C. albicans isolates in a murine model of invasive candidiasis. Quantiﬁcation of
organisms and inﬂammatory changes in kidneys of infected animals were evaluated in a blinded, systematic manner. Average 7-day
mortality among animals infected with C. dubliniensis was 21.0% (33/157 animals; range for strains: 0–57.1%); and with C. albicans
23.2%, (23/99 animals; range for strains: 6.7–85.0%) (p 0.65). Greater strain variation was noted within species than between the two
species. Both species comprised strains of either high or low virulence, and six of the nine C. dubliniensis strains showed negligible vir-
ulence. Colony counts determined on samples from liver and kidneys did not differ between species. According to histopathological
analysis, C. dubliniensis produced signiﬁcantly lower levels of hyphae than C. albicans (p <0.001). Candida albicans caused a greater
inﬂammatory response in kidneys (p <0.001) and was more commonly associated with granulomatous inﬂammation (p 0.003) and
greater mononuclear inﬁltrate (p <0.001). According to multivariate analysis, increasing tissue burden of both hyphal forms (p 0.032)
and yeasts (p 0.016) was independently associated with death, whereas higher levels of mononuclear cells were protective (p <0.001).
The results suggest a great overlap between the virulence properties of C. dubliniensis and C. albicans. Both yeast and hyphal forms are
independently associated with mortality, suggesting similar virulence for both. The source of the fungal isolates may be a neglected
confounding factor in virulence studies in animal models.
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Introduction
The incidence of candidaemia has increased markedly in
the past decades. The reasons for this increase are multi-
ple, including a greater number of vulnerable patients,
more extensive surgical procedures, the increasing use of
large vascular catheters (primarily central venous cathe-
ters), and progress in the treatment of serious bacterial
infections [1,2]. Candida species are the most common
cause of fungal disease in humans, with C. albicans
reported as the most common causative agent of systemic
candidiasis [3]. At the same time, previously unrecognized
fungal species have been identiﬁed. In 1995 Sullivan et al.
identiﬁed C. dubliniensis, which had previously been recog-
nized as ‘atypical C. albicans’ [4]. Candida dubliniensis was
initially thought to be less virulent than C. albicans, and
hardly capable of causing invasive infections, such as blood-
stream infections. However, although it still comprises a
low proportion of systemic fungal infections in large epide-
miological studies (<1%) [5,6], candidaemia caused by
C. dubliniensis has been increasingly reported [7–9] in
patients with a wide variety of underlying diseases [10–15].
A population-based study of candidaemia in Iceland from
1995 to 1999 [16] revealed three infections (4%) caused
by C. dubliniensis, which had originally been identiﬁed as
C. albicans, and during the period 2000–2006 that propor-
tion increased to 6%.
Candida dubliniensis is phenotypically similar to C. albicans
in many respects, being polymorphic and producing
chlamydospores. However, its phylogenic and genotypic
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characteristics are distinct from C. albicans [17,18]. The two
species seem to possess different virulence traits, as shown
by in vitro and in vivo virulence studies. The ability to adhere
to epithelial cells, to produce phospholipase and proteinases,
and to form hyphae and pseudohyphae may be attenuated
among C. dubliniensis strains [19–21]. In contrast, phenotypic
switching of colony morphology and adaptive resistance to
ﬂuconazole and other azole agents seems to be a more com-
mon trait in C. dubliniensis [20,22].
The virulence properties of the two species have been
compared in two previous studies [23,24] using a murine
model of systemic bloodstream infection. Survival of mice
infected by C. albicans was signiﬁcantly impaired in compari-
son with animals infected with C. dubliniensis in one study
[24], but was marginal in another study [23]. Candida albi-
cans has also been shown to be more effective in dissemina-
tion from the gastrointestinal tract in immunocompromised
animals [19]. All these studies have two major limitations in
common: a low number of strains used and/or an apparent
lack of criteria for selection of fungal strains for the animal
experiments. Previous studies suggest that virulence proper-
ties of strains may be different, in part based on the source
(systemic vs. mucosal infections) [25–27]. In addition, a sig-
niﬁcant association has been found between genetic clades
of C. albicans and the anatomical source of isolates, reﬂect-
ing possible differences in putative virulence properties [28].
In order to adjust for this potential confounder, it is rea-
sonable to use isolates from analogous anatomical sources,
as well as comparable patients, for comparisons of the viru-
lence of the two species. The aims of this study were to:
(i) compare the virulence of C. dubliniensis, using a range of
bloodstream isolates (BSIs), with C. albicans in a murine
model of bloodstream infection in immunocompetent
animals; and (ii) evaluate in a blinded, systematic manner
the histopathological characteristics associated with this
infection. As we are unaware of any previously published
guidelines in this ﬁeld, we propose a scoring method for
systemic evaluation of these changes using blinding to
reduce bias.
Materials and Methods
Fungal isolates
All isolates tested were BSIs; nine C. dubliniensis and three
C. albicans, including one C. albicans ATCC 90028 reference
strain (Table 1). The isolates were initially identiﬁed using
growth phenotypes on CHROMagar medium (Hardy Diag-
nostics, Santa Maria, CA, USA) and API 20C and API id32C
substrate utilization proﬁles (bioMe´rieux, Marcy l’Etoile,
France). Deﬁnitive species identiﬁcation was conﬁrmed by
sequence analysis of the internal transcribed spacer (ITS)
regions 1 and 2 with use of the fungal universal primers ITS1
and ITS4 as previously described [29]. All isolates were
unambiguously identiﬁed to the species level. All isolates
were kept at )70C in glycerol until use. Isolates CD-541,
1329, 1862 and CBS 8500 were generously provided by
D. Sullivan.
Antifungal susceptibility testing
The MICs of amphotericin B, ﬂuconazole and itraconazole
were determined for all isolates by using Etest (AB Biodisk,
TABLE 1. Candida bloodstream isolates used in this study
Species Isolate
Country
of origin
Year of
isolation
Age of
patient
Underlying patient
condition
30-day
survival
MIC
(lg/mL)
ﬂuconazole
MIC (lg/mL)
amphotericin
B
MIC (lg/mL)
itraconazole
Source/
reference
C. dubliniensis IS-30 Iceland 1996 68 Rectal cancer, COPD 30/30a 0.19 0.023 0.064 This study
IS-38a Iceland 1997 34 Insulin-dependent diabetes 30/30 0.125 0.047 0.008 This study
IS-57 Iceland 1999 42 AML; NP 12/30 8 0.023 0.125 This study
IS-124 Iceland 2001 73 CLL; Hodgkin’s disease; NP 9/30 1.5 0.016 0.25 This study
IS-176 Iceland 2004 56 Vasculitis unsp.; MOF 8/30 0.38 0.016 0.004 This study
CD-541 UK 1997 N/A N/A N/A 0.38 0.047 0.064 [40]
1329 Ireland 1995 35 Metastatic cervical
carcinoma; S/P laparotomy
1/30 0.047 1.5 0.004 [10]
1862 Ireland 1998 63 Ovarian carcinoma; S/P
laparotomy
N/A 0.125 0.125 0.016 [10]
CBS 8500 Netherlands 1995 39 CML; S/P HSCTx; GVHD 21/30 0.125 0.064 0.047 [11]
C. albicans ATCC 90028 USA N/A N/A N/A N/A 0.19 0.19 0.094 http://www.atcc.org
IS-7 Iceland 1993 62 Multiple myeloma; NP 4/30 1.5 0.19 0.008 This study
IS-52 Iceland 1998 58 Non-Hodgkin’s lymphoma;
NP
30/30 8 0.016 0.016 This study
COPD, chronic obstructive pulmonary disease; AML, acute myelogenous leukaemia; NP, neutropenia; CLL, chronic lymphocytic leukaemia; MOF, multiorgan failure; N/A, not
available; S/P, stage-post; CML, chronic myelogenous leukaemia; HSCTx, haematopoietic stem cell transplantation; GVHD, graft-versus-host disease.
aPatient alive 30 days after positive blood culture for Candida sp.
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Solna, Sweden) with RPMI agar with 2% glucose, according
to instructions from the manufacturer (http://www.
abbiodisk.com).
DNA ﬁngerprinting and genotyping
Genomic DNA was extracted using a protocol described
previously by Xu et al. [30]. The nine C. dubliniensis isolates
were genotyped by PCR ampliﬁcation with use of the
genotype-speciﬁc primer pairs G1F/G1R, G2F/G2R, G3F/
G3R and G4F/G4R, as described previously by Gee et al.
[31]. These primers allow C. dubliniensis isolates to be
grouped into one of four genotypes, based on genotype-
speciﬁc differences in the nucleotide sequence of the ITS1
and ITS2 regions of the rRNA gene cluster [31].
Intraspecies genotypic diversity of the isolates was deter-
mined by a PCR ﬁngerprinting method for both species,
described in detail elsewhere [32]. In brief, template DNA
was ampliﬁed by arbitrarily-primed PCR (AP-PCR) with four
single primers [M13; (GACA)4; PA03; T3B] and the ampliﬁca-
tion products were separated by electrophoresis. The elec-
trophoretic bands were sized and scored manually and with
BioNumerics, version 4.61 (Applied Maths, Sint-Martens-
Latem, Belgium). A dendrogram was generated using the
Dice coefﬁcient and the unweighted-pair group method with
use of average linkages.
Animal experiments
Adult (6–10 weeks of age) female non-immunosuppressed
NMRI mice (mean weight, 29 g) were obtained from M&B
AS (Ry, Denmark). The infective inoculum was generated
by suspending two–three colonies in sterile saline for a
ﬁnal concentration of 5–8 · 106 organisms/mL. The volume
was adjusted appropriately by measurements of optical
density (OD) and with use of a counting chamber. Final
concentration was veriﬁed by viability counting on solid
media. The mice were infected with an inoculum of 200 lL
(1–2 · 106 organisms) of the yeast suspension by injection
into the lateral tail vein, using a 27-G needle and tuberculin
syringes to ensure accurate volume. A total of 157 mice
were infected with the nine C. dubliniensis isolates and 99
mice were infected with the three C. albicans isolates. The
animals were kept in cages with free access to commercial
pelleted food and water under standardized conditions at
the Institute of Experimental Pathology at Keldur (Reykja-
vik, Iceland) with regulated daylight and temperature. Mice
were monitored three times daily for 7 days after the
infection, and mortality was noted. If they appeared to be
in pain or pre-terminal they were euthanized. At the end
of the experiments all live animals were sacriﬁced. The ani-
mal experiments were authorized by the Experimental Ani-
mal Committee of Iceland and complied with animal
welfare act 15/94.
Viability counting and histopathological analysis
Both kidneys and the liver were removed. The liver and one
kidney were homogenized (Omni tissue homogenizer; Omni,
Gainesville, VA, USA) in 1.8 mL cold saline. The yeast densi-
ties were determined by plating serial ten-fold dilutions on
Sabouraud agar with chloramphenicol (Oxoid, Basingstoke,
UK). Colony counts were performed after 48 h of incubation
at 35C. The other kidney was ﬁxed in 10% buffered formal-
dehyde and prepared for histopathological examination,
embedded in parafﬁn, cut into 5-lm thick sections, and
stained by haematoxylin-eosin stain and methenamine-silver
stain. Kidneys from 235 mice were available for histopatho-
logical analysis. The sections were marked with encrypted
numbers and examined in a blinded manner without knowl-
edge of the infective strain. The following characteristics
were systematically scored for each specimen according to a
predetermined scoring system as shown in Fig. 1: tissue bur-
den of organisms (0–4); presence, localization, and propor-
tion of yeast forms vs. hyphae/pseudohyphae; inﬂammatory
response [degree (0–4), localization, and type]; amount of
neutrophils (0–4) and mononuclear cells (0–4); presence of
microabscesses (+/)), and granulomas (+/)). The specimens
were decrypted after all sections had been evaluated and the
results recorded in a database (SPSS version 11.0; SPSS Inc.,
Chicago, IL, USA).
Statistical analysis
Survival of the animals was compared using Kaplan–Meier
analysis and the log rank test. The non-parametric Mann–
Whitney test was used to compare CFU/mL (log10)
between groups. The Pearson chi-square test and Fisher’s
exact test were used, as appropriate, to assess the bivariate
relationship among categorical variables, in particular how
death rate and fungal species were related to other vari-
ables. For ordinal variables a linear-by-linear association was
used. To further assess factors associated with death, step-
wise multivariable logistic regression analysis was performed
with death at day 7 as the dependent variable. The follow-
ing variables were tested: amount of hyphae (fungal load
multiplied by the proportional amount of hyphae/pseudohyp-
hae, 0–4), amount of yeast forms (fungal load multiplied by
the proportional amount of yeast forms, 0–4), amount of
mononuclear cells (0–4), amount of neutrophils (0–4), and
fungal species (C. albicans vs. C. dubliniensis). The level of
signiﬁcance was set at p <0.05. All tests were two-tailed.
Statistical analysis was performed by using SPSS version 11.0
(SPSS Inc.).
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Results
Candida isolates
A description of the three C. albicans and nine C. dubliniensis
isolates used in this study is given in Table 1. As shown, the
source patients had a wide variety of underlying conditions,
most commonly haematological and solid organ malignancies,
with or without neutropenia.
All Candida isolates were susceptible to ﬂuconazole (MIC
range, 0.047–8 mg/L) and itraconazole (MIC range, 0.004–
0.25 mg/L) [33]. One Irish C. dubliniensis isolate was resistant
to amphotericin B (MIC, ‡1 mg/L); all others were susceptible.
All isolates were identiﬁed to the species level with use of
ITS sequence analysis and the C. dubliniensis isolates were
genotyped by PCR with genotype-speciﬁc primer pairs [31].
Six of the nine C. dubliniensis isolates, including four of the
ﬁve Icelandic isolates, belonged to genotype 1 (Fig. 2). Two
isolates belonged to genotype 2 and one isolate (IS-124)
yielded amplimers with both genotype 1- and genotype 2-
speciﬁc primers. According to AP-PCR with four single prim-
ers, all C. dubliniensis isolates had distinct PCR ﬁngerprinting
(a) (e)
(b) (f)
(c) (g)
(d) (h)
FIG. 1.Quantiﬁcation of tissue burden of
organisms and inﬂammatory responses in kid-
neys of animals infected with Candida albicans
and C. dubliniensis. A scoring system of 0–4 for
each parameter was developed. For quantiﬁca-
tion of fungal load, kidney slices were stained by
methenamine-silver stain and scored as 0 (if no
yeasts were visible) or as 1, 2, 3 or 4 (ﬁgures a,
b, c and d, respectively). For estimation of
inﬂammatory responses, slices were stained
with haematoxylin-eosin stain (H&E) and the
amount of inﬂammatory cells was scored in the
same way as fungal load (ﬁgures e, f, g and h,
respectively). Magniﬁcation 310·.
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proﬁles without evidence of clonality, representing different
strains (Fig. 2).
Animal experiments
Survival. After 7 days of observation, a total of 21.0% (33/
157) of mice infected with C. dubliniensis had died, compared
with 23.2% (23/99) of mice infected with C. albicans (p 0.65).
However, marked variation in survival was observed accord-
ing to the infecting strain (Fig. 3). This applied to both Can-
dida species, with most fatalities occurring on days 4 and 5.
Six of the nine C. dubliniensis strains tested were not associ-
ated with any deaths.
Load of organisms in internal organs. Table 2 details the results
from colony counts in internal organs. For both species, a
signiﬁcantly greater load of yeasts was noted in kidneys
(median, 2.7 · 104 CFU/mL, range, 0–3.5 · 107) compared
with livers (median 7.3 · 102, range, 0–2.5 · 106; p 0.001).
Colony counts in both organs did not differ signiﬁcantly
between fungal species for animals given the same infective
dose (1–2 · 106 organisms, p >0.4). A wide variation in tis-
sue burden was noted, with as high as a 1000-fold difference
between strains belonging to the same species.
Histopathological analysis in kidneys. The results from the
blinded histopathological analysis are summarized in Table 3.
Kidneys from 235 animals were examined; 89 were inocu-
lated with C. albicans and 146 with C. dubliniensis (89% and
93% of infected animals, respectively).
The fungal load observed by histopathological analysis did
not differ between the two species (p 0.078). When all kid-
neys were analysed, the yeasts were predominately in the
yeast form in 77.9% of kidney sections, whereas in 20.4% the
hyphal form prevailed. C. albicans formed pseudohyphae and
true hyphae to a signiﬁcantly greater degree than C. dublinien-
sis (p <0.001), in most part due to the intense formation
seen in animals infected with the highly virulent strain IS-7
(Table 3). Similar results were obtained when highly virulent
strains of both species were analysed independently; the
hyphal form dominated in 16 (80%) of 20 kidney sections
infected with IS-7, compared with 20 (36%) of 56 sections
infected with the highly virulent C. dubliniensis, IS-30 and IS-
38a (p 0.001). Yeasts and inﬂammatory cells were equally
10
0
95908580757065605550
IS-7
ATCC 90028
IS-52
1329
CBS 8500
1862
CD-541
IS-38a
IS-57
IS-30
IS-176
IS-124
C. dubliniensis
C. albicans
–
–
–
Genotype 1
Genotype 1
Genotype 2
Genotype 2
Genotype 1
Genotype 1
Genotype 1
Genotype 1
Genotype 1/2*
FIG. 2. Phylogenetic relationships of the Candida isolates used in this study as determined by PCR ﬁngerprinting. Combined results from PCR
with four single primers [M13; (GACA)4; PA03; T3B] are shown. Unweighted pair-group method using average linkages and the Dice coefﬁcient
were used to construct the dendrogram. The genotypes of the C. dubliniensis isolates are given on the right. *Isolate IS-124 yielded an amplimer
with both genotype 1- and genotype 2-speciﬁc primer pairs.
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FIG. 3. Survival of mice infected by Candida albicans (three isolates,
n = 99) compared with C. dubliniensis (nine isolates, n = 157). Sur-
vival was monitored three times daily for 1 week. Other C. dublinien-
sis strains: IS-124; IS-176; CD-541; 1329; 1862; and CBS 8500.
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distributed throughout different parts of the kidneys and
their location was not associated with fungal species or mor-
tality. In four sections (1.7%), no yeasts were visible.
The type of inﬂammatory response was not signiﬁcantly
different between fungal species. Mixed acute and chronic
inﬂammation was observed in almost half of the kidney
sections (115/235), with acute inﬂammation predominating
in 76 (32.3%) specimens and chronic inﬂammation in 44
(18.7%). Signiﬁcantly greater inﬂammation was noted in the
kidneys after infection with C. albicans in comparison with
C. dubliniensis (p <0.001), although marked variation was
again observed for different strains of each species. How-
ever, this observed difference remained signiﬁcant when
highly virulent strains of both species were independently
analysed (IS-7 vs. IS-30 and IS-38a, p <0.001). C. albicans
was also more commonly associated with preponderant
chronic granulomatous inﬂammation (p 0.003) and a
greater amount of mononuclear cells (p <0.001).
Correlates of outcome. The association between histopatholog-
ical variables and outcome according to univariate and multi-
variate analysis is summarized in Table 4. Higher fatality
ratios at day 7 were signiﬁcantly associated with greater fun-
gal load in kidneys, with the amount of acute inﬂammatory
changes, and with increasing degree of formation of hyphae/
pseudohyphae relative to the budding yeast form (p <0.001).
Chronic inﬂammatory changes were, however, associated
with reduced mortality (p <0.001).
When multivariable stepwise logistic regression analysis
was performed to study the association of these parameters
with outcome, three parameters were independently associ-
ated with outcomes. Higher levels of mononuclear cells in
infected tissue were signiﬁcantly associated with lower mor-
tality, whereas increasing tissue burden of both hyphal forms
and budding yeasts was independently associated with death
(Table 4).
Discussion
To our knowledge, this is the ﬁrst study to compare the vir-
ulence of C. dubliniensis and C. albicans in a murine model of
bloodstream infection, using several C. dubliniensis isolates
from comparable infections. In addition, we evaluated the
accompanying histopathological changes systematically and in
a blinded manner. We did not observe a signiﬁcant differ-
ence in the virulence of C. albicans and C. dubliniensis when
results from all isolates of each species were combined.
Indeed, a greater variation in mortality was noted among dif-
ferent strains of each species than between the fungal species
themselves. Both species comprised strains of high and low
virulence, and six of the nine C. dubliniensis strains were
virtually avirulent. Greater fungal dissemination of kidneys,
irrespective of yeast or hyphal morphology, was an indepen-
dent risk factor for death.
A murine model of bloodstream infection is an established
method for effective comparison of the pathogenicity of dif-
ferent Candida species [34]. Although studies using isolates
from comparable patients and clinical sites are lacking, two
other investigators have used this model to compare the vir-
ulence properties of C. albicans and C. dubliniensis. Gilﬁllan
et al. [23] compared the virulence of four mucosal isolates of
C. dubliniensis with one systemic isolate of C. albicans. The
mice infected with C. dubliniensis survived longer, although
the difference was marginal. Vilela et al. [24] compared seven
isolates of C. albicans from sites other than blood with seven
C. dubliniensis isolates of unspeciﬁed origin. In general, the
composite survival rate was signiﬁcantly lower in C. albicans-
TABLE 2. In vivo virulence of Candida albicans and C. dubliniensis in a murine model of bloodstream infection
Species Isolate
No. of
mice
Median
inoculum
(organisms)a
Mean
survival
time (day)
No. of
survivors
at day 7 (%)
Liver (CFU/mL)
median (range)
Kidney (CFU/mL),
median (range)
C. dublinien-
sis
IS-30 28 1.0 · 106 5.11 12 (42.9) 3.1 · 104 (0–2.5 · 106) 2.4 · 105 (0–3.5 · 107)
IS-38a 28 1.1 · 106 5.24 13 (46.4) 2.0 · 104 (9.2 · 101–1.9 · 106) 1.2 · 105 (1.2 · 104–1.2 · 107)
IS-57 30 1.2 · 106 6.89 28 (93.3) 9.9 · 101 (0–1.8 · 104) 2.2 · 104 (3.3 · 102–1.8 · 106)
IS-124 21 1.0 · 106 7 21 (100) 9.7 · 102 (9.2 · 101–9.8 · 104) 6.3 · 104 (7.4 · 101–6.6 · 105)
IS-176 10 1.0 · 106 7 10 (100) 2.9 · 102 (9 · 101–1.5 · 103) 1.7 · 104 (4 · 103–5.5 · 104)
CD-541 10 1.0 · 106 7 10 (100) 5.7 · 103 (1.5 · 103–2 · 104) 1.3 · 104 (2.4 · 103–5.8 · 104)
IR-1329 10 1.1 · 106 7 10 (100) 1.5 · 103 (2.3 · 102–9.5 · 103) 2.4 · 103 (6.1 · 102–8.6 · 103)
IR-1862 10 1.0 · 106 7 10 (100) 6.3 · 101 (1.3 · 101–5.3 · 102) 4.1 · 103 (9.6 · 102–7.4 · 103)
CBS 8500 10 1.1 ·106 7 10 (100) 2.8 · 102 (9.8 · 101–1.2 · 104) 1.9 · 104 (5.7 · 103–6.7 · 104)
C. albicans ATCC 90028 49 1.1 · 106 6.74 45 (91.8) 2.3 · 102 (0–1.1 · 105) 1.0 · 104 (4.7 · 102–3.3 · 106)
IS-7 20 1.0 · 106 4.43 3 (15.0) 2.9 · 104 (3 · 103–5.3 · 104) 3.4 · 106 (8.6 · 103–7.9 ·106)
IS-52 30 1.1 · 106 6.77 28 (93.3) 5.5 · 102 (2 · 101–1.5 · 106) 2.2 · 104 (3.1 · 103–1.2 · 105)
aThe lethal dose needed to kill 50% of the animals (LD50) was determined for C. albicans ATCC 90028 and subsequent experiments conducted using this strain as a refer-
ence.
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infected mice compared with C. dubliniensis-infected mice.
The discrepancy between our results and these two studies
may be related to the source of the isolates.
Isolates from different anatomical sites may differ in their
virulence potential. A study by Cassone et al. [25] showed
that environmental isolates, vaginal isolates, and BSIs of
Candida differed with respect to production of aspartyl
proteinases and experimental pathogenicity, with BSIs being
generally more virulent. Similarly, it has been suggested that
bioﬁlm production and secretion of hydrolytic enzymes are
signiﬁcantly more common virulence traits among Candida
isolates from the bloodstream than from other sites [26,35].
Isolates from systemic infections also differ signiﬁcantly from
isolates from mucosal infections with respect to genetic
clades, as determined by multilocus sequence typing, reﬂect-
ing the potential association between clades and putative
virulence factors [28]. We therefore believe that attention
to the source of isolates is of paramount importance in viru-
lence studies.
All Candida BSIs tested in the current experiments had
distinctive PCR ﬁngerprinting proﬁles, representing 12 differ-
ent strains. Among C. dubliniensis, genotype 1 predominated
(6/9, 67%), which is consistent with results from the study of
Gee et al. [31], where 72% (71/98) of isolates, recovered
from 15 different countries, belonged to genotype 1. We didT
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TABLE 4. Histopathological variables associated with case
fatality in mice infected with Candida albicans and
C. dubliniensis
Variablea OR (95% CI)b p value
Univariate analysis
Yeast parameters
Fungal load (0–4) 15.876 (7.580–33.252) <0.001
Amount of hyphae/pseudohyphaec 2.646 (1.914–3.658) <0.001
Amount of budding yeastsd 1.152 (1.064–1.247) 0.001
Increasing proportion of hyphal vs.
yeast forms
12.298 (6.135–24.651) <0.001
Inﬂammation
Amount of inﬂammatory inﬁltrate (0–4) 4.866 (3.037–7.797) <0.001
Neutrophils present 4.798 (0.279–85.421) 0.204
Amount of neutrophils (0–4) 12.515 (6.531–23.982) <0.001
Mononuclear cells present 0.003 (0.001–0.015) <0.001
Amount of mononuclear cells (0–4) 0.046 (0.019–0.110) <0.001
Microabscesses present 51.652 (6.994–381.47) <0.001
Granulomas present 0.033 (0.002–0.553) <0.001
Multivariate analysis
Amount of hyphae/pseudohyphae 2.269 (1.072–4.802) 0.032
Amount of budding yeasts 2.063 (1.144–3.720) 0.016
Amount of mononuclear cells 0.017 (0.002–0.151) 0.001
Amount of neutrophils 3.597 (0.375–34.489) 0.267
Fungal speciese 1.797 (0.053–61.123) 0.745
OR, odds ratio; CI, conﬁdence interval.
aValues 0–4 refer to the scoring system depicted in Fig. 1.
bFor ordinal variables, increase in OR for each 1 score increase (scores as given
in Fig. 1).
cCalculated from the observed amount of fungal load in histopathological analy-
sis of kidneys and the relative proportion of hyphal formations (pseudohyphae
and true hyphae).
dCalculated from the observed amount of fungal load in histopathological
analysis of kidneys and the relative proportion of budding yeast forms.
eIn the ﬁnal model, C. albicans served as a reference species.
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not observe an association between genotype and virulence
in the murine model.
Although our experiments show no signiﬁcant difference
in the composite survival rate of animals infected with C. dub-
liniensis in comparison with C. albicans, marked variation in
virulence was noted among strains. The most virulent C. dub-
liniensis strains were IS-30 and IS-38a, with 43% and 46%
7-day survival rates, respectively. However, six of the nine
C. dubliniensis strains were not associated with any deaths.
Among C. albicans, IS-7 was the one associated with the high-
est mortality rate, with only 15% survival at day 7. The slope
of the survival curve for mice infected with the three most
virulent strains was comparable, with most animals succumb-
ing to the infection on day 4–5. Our results are not directly
comparable to the observations reported by Gilﬁllan et al.
and Vilela et al., but both of these studies reported great var-
iation in the survival of animals infected with different C. dub-
liniensis isolates, ranging from virtually avirulent to highly
virulent [23,24]. However, this variation was not described
in detail.
In order to analyze the observed variations in virulence
among the different isolates, we evaluated the accompanying
histopathological changes in kidneys of the infected animals
in a blinded, systematic manner. Higher levels of mononu-
clear cells in kidney sections were independently associated
with lower death rates at day 7, reﬂecting a successful immu-
noresponse. A signiﬁcantly greater inﬂammatory response
was noted in kidneys seeded with C. albicans compared with
those seeded with C. dubliniensis. Granulomatous inﬂamma-
tion and greater mononuclear inﬁltrate were also more com-
monly noted with C. albicans. The inﬂammatory responses to
systemic infections with C. albicans and C. dubliniensis have
not been systematically recorded previously, but, contrary to
our results, Vilela and co-workers [24] observed a generally
stronger inﬂammatory reaction in histopathological analysis
of kidneys infected with C. dubliniensis in comparison with
those infected with C. albicans. However, the type or amount
of inﬂammatory inﬁltrate was not speciﬁed in detail.
One of the most extensively studied virulence traits of
C. albicans and C. dubliniensis is their ability to form true
hyphae and pseudohyphae in order to invade host tissues
and cause deep-seated infections. Our results show that
C. albicans, in particular the highly virulent strain IS-7, formed
hyphae and pseudohyphae to a signiﬁcantly greater degree
than C. dubliniensis. However, when all strains were
combined, hyphal formation was not an independent predic-
tor of mortality. Similarly, previous studies have shown that
hyphal production of C. albicans exceeds that of C. dubliniensis,
both in vivo [24] and under most conditions that promote
this morphological transition in vitro, including growth in
serum and shifts in pH and temperature [19]. A recent sur-
vey comparing the genome of C. dubliniensis and that of C. albi-
cans with the use of DNA microarrays revealed that several
hyphae-speciﬁc virulence-associated genes of C. albicans were
absent (secreted aspartyl proteinase genes SAP5 and SAP6)
or divergent (hyphal wall protein 1 gene) in C. dubliniensis
[36], which could, in part, explain this difference. Differences
in gene expression among the two species have also been
described, relating to differential control of the NRG1 regu-
lator gene, a well-known repressor of ﬁlamentation in C. albi-
cans [37–39].
Although the importance of hyphal production in Candida
pathogenicity is undisputed, the yeast form can also dissemi-
nate and multiply in internal organs. The ability of C. dublinien-
sis to traverse the mucosal barrier of the gastrointestinal
tract may be attenuated compared with the ability of C. albi-
cans [19], but nevertheless, our results show that, once
inside the bloodstream, it can cause serious deep-seated
infections with mortality comparable to that due to C. albi-
cans. The fact that ﬁlamentation remained signiﬁcantly more
common among animals seeded with C. albicans in compari-
son with those seeded with C. dubliniensis, when highly viru-
lent isolates of both species were independently analysed,
suggests that other virulence factors may be more important
in the pathogenesis of invasive C. dubliniensis infections.
The most important limitation of the current study was
the relatively low number of C. albicans isolates tested, com-
pared with C. dubliniensis. However, to our knowledge no
other studies have used a commensurable number of systemic
C. albicans strains to compare their virulence traits with those
of C. dubliniensis strains. The C. albicans strains tested also had
a broad virulence range, ranging from low to high virulence.
Also, it can be argued that, by working with BSIs, we have
selected isolates that are more virulent, surpassing the natu-
ral barrier of infection. We used non-immunocompromised
animals, but the correlation between virulence in animal
models and humans has not been formally studied. Given the
absence of a better alternative, we believe, however, that
the current study provides more realistic information than in
vitro studies.
In summary, we compared the virulence of C. albicans
and C. dubliniensis in a murine model using several C. dublinien-
sis BSIs. We observed greater strain variation within species
than between the two species, with both species comprising
highly virulent strains. Our results also show that factors other
than fungal morphology in tissues may account for the
observed variation in mortality of the animals. Virulence differ-
ences may, in part, be attributed to the amount and type of
systemic and local immune responses evoked by different
Candida, as well as to the host’s antibody response to fungal
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cell wall antigens, which is the current focus of our research.
The origin of the isolates may be a neglected confounding fac-
tor in virulence studies. Ideally, for meaningful comparisons,
many representative isolates from each species should be
used.
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